Acumen Research and Consulting

Real-Time PCR (QPCR) and Digital PCR (DPCR) Market to Cross US $4.2 Billion by 2026

Real-time PCR (qPCR) and Digital PCR (dPCR) Market By Global Industry Analysis, Market Size, Technology, Application, Opportunities and Forecast, 2019 - 2026

 

Pune, India -- (SBWIRE) -- 05/28/2019 -- The Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market is estimated to grow at CAGR above 8.1 % over the forecast time frame 2019-2026 and reach the market value around USD 4.2 billion by 2026.

In order to amplify or produce a number of copies of the deoxyribonucleic acid (DNA) sequence, polymerase (PCR) technology will be utilized. The PCR technology covers several applications, such as DNA cloning, hereditary disease diagnosis, gene functional analysis, paternity testing, infectiity detection, and forensic sciences. The technology uses Polymerasis chain reaction (PCR). Two major types of polymerase chain reaction (PCR) technologies are the digital PCR (dPCR) and the quantitative PCR (qPCR).

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1392

Growing demand for quick diagnostic tests is one of the drivers of this market's elevated effect rendering. Demand for RDTs is probable to be growing with local authorities worldwide attempting to take these trials into account to better diagnose and treat infectious illnesses.

The introduction in distant regions with restricted health care facilities, of RDTs as an significant instrument for managing infectious disease, is probable to stimulate the development of technologies used widely in Polymerase Chain Reaction (PCR) for these diagnostic processes.

In addition, one of the major factors contributing to market growth is the high prevalence of infectious diseases. Lower respire infections, diarrheal and tuberculosis were among the world's top ten cause of death in 2016, according to estimates by the World Health Organization (WHO). The need for better diagnosis options in development countries is continued to increase in new cases of other infectious diseases such as malaria, HIV, among others. In developing countries, the patient population is likely to rise substantially.

In addition, other factor which is expected to boost market activity during the forecast period include inorganic growth strategies such as merger and acquisitions by leading PCR manufacturers in expanding the portfolio and developing new qPCR and dPCR products. As for example, the company's position in droplets digital computer PCR and next-generation sequences was acquired by Bio-Rad Laboratories, Inc. in January 2017.

Key Findings

Due to its precision and wide application of pathogen detection, gene expression, and microRNA analysis technologies, qPCR held the biggest market share in 2018. Because of exact quantification of target sequences, the digital PCR is estimated to be the fastest growing segment.

Consumables and reagents are the product segment leading and are likely to have a highly significant increase in use of PCR sets in diagnostic testing over the forecast period of more than 8.5 %.

Due to the widespread use in research areas such as agriculture and microbiology, stem cells, the research application was the larger value segment in 2018.

Due to automated processes, robust growth is expected to occur during clinical application during the forecast period.

In 2018, the biggest market share in North America was the result of the new PCR products launched in conjunction with the increasing demand for fast diagnostic tests.

Asia Pacific is projected, due to a rising patient population due to the frequency of infectious diseases, to record comparatively significant growth during the forecast period.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/real-time-pcr-qpcr-and-digital-pcr-dpcr-market

Players & Strategies

Major players in the market have always been focused on implementing strategic commercial measures to maintain their competitive position. New product launches, collaborations and partnerships with institutions and businesses, as well as merger and acquisitions are key measures adopted by the players.

For example, in January 2019, in an agreement worth USD 260 million, FORMULATRIX announced the acquisition of QIAGEN N.V., digital PCR assets. The acquisition will well increase with the strategy of the company to launch new digital PCR platforms in 2020 by using the state-of - the-art dPCR technology of FORMULATRIX.

Some of the prominent competitors dominating the qPCR and dPCR industry include Abbott Laboratories Inc.; Bio-Rad Laboratories; Thermo Fisher Scientific Inc.; Agilent Technologies, Inc., Hoffmann La Roche, Qiagen N.V. ; and Fluidigm Corporation.

Browse all official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Real-time PCR (qPCR) and Digital PCR (dPCR)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Real-time PCR (qPCR) and Digital PCR (dPCR) Market By Technology
1.2.2.1. Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue Share By Technology in 2017
1.2.2.3. Digital
1.2.2.4. Quantitative
1.2.3. Real-time PCR (qPCR) and Digital PCR (dPCR) Market By Product
1.2.3.1. Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.3.1.1. Instruments
1.2.3.1.2. Reagents and Consumables
1.2.3.1.3. Software & Services
1.2.4. Real-time PCR (qPCR) and Digital PCR (dPCR) Market By Application
1.2.4.1. Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Research
1.2.4.2.1. Forensic and Others
1.2.4.3. Clinical
1.2.4.3.1. Pathogen Testing
1.2.4.3.2. Oncology Testing
1.2.4.3.3. Blood Screening
1.2.4.3.4. Others
1.2.5. Real-time PCR (qPCR) and Digital PCR (dPCR) Market by Geography
1.2.5.1. Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Real-time PCR (qPCR) and Digital PCR (dPCR) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Real-time PCR (qPCR) and Digital PCR (dPCR) Major Manufacturers in 2017
3.3. R&D Status and Technology Technology of Global Real-time PCR (qPCR) and Digital PCR (dPCR) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Real-time PCR (qPCR) and Digital PCR (dPCR) Major Manufacturers in 2017

CHAPTER 4. REAL-TIME PCR (QPCR) AND DIGITAL PCR (DPCR) MARKET BY BY TECHNOLOGY

4.1. Global Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue By Technology
4.2. Digital
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Quantitative
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. REAL-TIME PCR (QPCR) AND DIGITAL PCR (DPCR) MARKET BY PRODUCT

5.1. Global Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue By Product
5.2. Instruments
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Reagents and Consumables
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Software & Services
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. REAL-TIME PCR (QPCR) AND DIGITAL PCR (DPCR) MARKET BY APPLICATION

6.1. Global Real-time PCR (qPCR) and Digital PCR (dPCR) Revenue By Application
6.2. Research
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.2.3. Forensic and Others
6.3. Clinical
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3.3. Pathogen Testing
6.3.4. Oncology Testing
6.3.5. Blood Screening
6.3.6. Others

CHAPTER 7. NORTH AMERICA REAL-TIME PCR (QPCR) AND DIGITAL PCR (DPCR) MARKET BY COUNTRY

7.1. North America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE REAL-TIME PCR (QPCR) AND DIGITAL PCR (DPCR) MARKET BY COUNTRY

8.1. Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC REAL-TIME PCR (QPCR) AND DIGITAL PCR (DPCR) MARKET BY COUNTRY

9.1. Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA REAL-TIME PCR (QPCR) AND DIGITAL PCR (DPCR) MARKET BY COUNTRY

10.1. Latin America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST REAL-TIME PCR (QPCR) AND DIGITAL PCR (DPCR) MARKET BY COUNTRY

11.1. Middle East Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA REAL-TIME PCR (QPCR) AND DIGITAL PCR (DPCR) MARKET BY COUNTRY

12.1. Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Real-time PCR (qPCR) and Digital PCR (dPCR) Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Abbott Laboratories Inc
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Bio-Rad Laboratories
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Thermo Fishe Scientific Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Thermo Fisher Scientific Inc.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Agilent Technologies, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Hoffmann La Roche
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Qiagen N.V.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Fluidigm Corporation
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Others
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1392

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report - https://www.acumenresearchandconsulting.com/buy-now/0/1392

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.